IN-DATE
5905310: Bard Equistream Long Term Hemodialysis Catheter: Alphacurve, Standard, 14.5F x 31cm
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $12.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 2 eaches |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 13 hours 56 minutes and choose overnight shipping at checkout. |
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in date item only.
Additional Details
BD Bard Equistream Long Term Hemodialysis Catheter - Standard Kit
- Adhesive Dressings (2)
- AirGuard® Valved Introducer - 15F x 13cm
- Connector Caps (2)
- Dilator, 8F
- Dual Lumen Catheter: 14.5F
- Dualator® Vessel Dilator - 10-12F
- Guidewire 0.038" x 70cm
- Guidewire Introducer Needle: 18G
- Tunneling Device
AccessGUDID Info
- FDA Product Code: MSD
- FDA Product Code Name: Catheter, hemodialysis, implanted
- GMDN Term Code: 37278
- GMDN Term Name: Double-lumen haemodialysis catheter, implantable
- GMDN Term Description: An implantable, flexible, double-lumen tube intended to be used for chronic or long-term (> 30 days) vascular access, primarily during haemodialysis, to conduct blood from a patient and returning it after extracorporeal circulation; it may also be used during haemoperfusion and/or apheresis. It is intended for coaxial flow of blood, may be radiopaque, coated with heparin to prevent thrombus formation, and/or include a silver-coated sleeve to retard bacterial growth; devices dedicated to catheter introduction/function (e.g., introducer needle) may be included.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
